Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angelo Di Leo

Showing results (41-50 of 187) with videos related to

Pageof 19
Sort By:
Breast Cancer Research : BCR|May 14, 2009
Recent advances in systemic therapy: new diagnostics and biological predictors of outcome in early breast cancerCatherine Oakman, Silvia Bessi, Elena Zafarana, et al.
NPJ Breast Cancer|July 20, 2017
A multifactorial 'Consensus Signature' by <i>in silico</i> analysis to predict response to neoadjuvant anthracycline-based chemotherapy in triple-negative breast cancerNatalie Turner, Mattia Forcato, Simona Nuzzo, et al.
Therapeutic Advances in Medical Oncology|December 22, 2018
Managing advanced HR-positive, HER2-negative breast cancer with CDK4/6 inhibitors in post-menopausal patients: is there a best sequence?Lorenzo Rossi, Amelia McCartney, Emanuela Risi, et al.
Critical Reviews in Oncology/Hematology|September 3, 2008
Taxanes in the elderly: can we gain as much and be less toxic?Laura Biganzoli, Sara Licitra, Erica Moretti, et al.
European Journal of Cancer (Oxford, England : 1990)|November 11, 2008
Topoisomerase II alpha as a marker predicting anthracyclines' activity in early breast cancer patients: ready for the primetime?Angelo Di Leo, Laura Biganzoli, Wederson Claudino, et al.
Nature Reviews. Clinical Oncology|May 27, 2015
Challenges in the management of advanced, ER-positive, HER2-negative breast cancerChristopher D Hart, Ilenia Migliaccio, Luca Malorni, et al.
Cancers|March 28, 2014
Can biomarker assessment on circulating tumor cells help direct therapy in metastatic breast cancer?Natalie Turner, Marta Pestrin, Francesca Galardi, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 18, 2008
Special focus on cardiac toxicity of different sequences of adjuvant doxorubicin/docetaxel/CMF regimens combined with radiotherapy in breast cancer patientsNicolas Magné, Pierre Castadot, Cyrus Chargari, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 16, 2007
Metabolomics: available results, current research projects in breast cancer, and future applicationsWederson Marcos Claudino, Alessandro Quattrone, Laura Biganzoli, et al.
Tumori|June 15, 2007
Gastric cancer metastatic to the pituitary gland: a case reportDaniele Pozzessere, Elena Zafarana, Anna Maria Buccoliero, et al.
Pageof 19

Showing results (41-50 of 187) with videos related to

Sort By:
Pageof 19
Breast Cancer Research : BCR|May 14, 2009
Recent advances in systemic therapy: new diagnostics and biological predictors of outcome in early breast cancerCatherine Oakman, Silvia Bessi, Elena Zafarana, et al.
NPJ Breast Cancer|July 20, 2017
A multifactorial 'Consensus Signature' by <i>in silico</i> analysis to predict response to neoadjuvant anthracycline-based chemotherapy in triple-negative breast cancerNatalie Turner, Mattia Forcato, Simona Nuzzo, et al.
Therapeutic Advances in Medical Oncology|December 22, 2018
Managing advanced HR-positive, HER2-negative breast cancer with CDK4/6 inhibitors in post-menopausal patients: is there a best sequence?Lorenzo Rossi, Amelia McCartney, Emanuela Risi, et al.
Critical Reviews in Oncology/Hematology|September 3, 2008
Taxanes in the elderly: can we gain as much and be less toxic?Laura Biganzoli, Sara Licitra, Erica Moretti, et al.
European Journal of Cancer (Oxford, England : 1990)|November 11, 2008
Topoisomerase II alpha as a marker predicting anthracyclines' activity in early breast cancer patients: ready for the primetime?Angelo Di Leo, Laura Biganzoli, Wederson Claudino, et al.
Nature Reviews. Clinical Oncology|May 27, 2015
Challenges in the management of advanced, ER-positive, HER2-negative breast cancerChristopher D Hart, Ilenia Migliaccio, Luca Malorni, et al.
Cancers|March 28, 2014
Can biomarker assessment on circulating tumor cells help direct therapy in metastatic breast cancer?Natalie Turner, Marta Pestrin, Francesca Galardi, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 18, 2008
Special focus on cardiac toxicity of different sequences of adjuvant doxorubicin/docetaxel/CMF regimens combined with radiotherapy in breast cancer patientsNicolas Magné, Pierre Castadot, Cyrus Chargari, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 16, 2007
Metabolomics: available results, current research projects in breast cancer, and future applicationsWederson Marcos Claudino, Alessandro Quattrone, Laura Biganzoli, et al.
Tumori|June 15, 2007
Gastric cancer metastatic to the pituitary gland: a case reportDaniele Pozzessere, Elena Zafarana, Anna Maria Buccoliero, et al.
Pageof 19